![Amir Reichman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 76 320 $ in data 31/05/2026
Amir Reichman was the founder of NeuroDerm Ltd. since 2003, holding the title of Chief Engineer & Senior Scientist from 2003 to 2009.
Mr. Reichman is currently the Chief Executive Officer & Director at Scinai Immunotherapeutics Ltd. since 2021.
Former positions include Head-Global Vaccines Engineering Core Technology at GlaxoSmithKline Pharmaceuticals SA (Belgium) from 2017 to 2021 and Head-Global Vaccines Value Chain Management at Novartis Vaccines & Diagnostics, Inc. (North Carolina) from 2011 to 2015.
Education includes an undergraduate degree from Ben-Gurion University of the Negev and an MBA from The Wharton School of the University of Pennsylvania.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/06/2026 | 67.540.000 ( 0,34% ) | 76 320 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Amministratore Delegato | 02/03/2021 |
| Società | Posizione | Fine |
|---|---|---|
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Corporate Officer/Principal | 01/03/2021 |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) | Corporate Officer/Principal | 01/01/2015 |
| NEURODERM LTD | Fondatore | 01/01/2009 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology Develops next-generation drug-device combination solutions for central nervous system disorders | Health Technology |
Scinai Immunotherapeutics Ltd.
 Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Vaccines & Diagnostics, Inc. (North Carolina) |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
